Inside one of the new production facilities the China National Biotec Group (CNBG) has built for manufacturing a Covid-19 vaccines CNBG announced that one of the potential vaccine candidates had completed phase one and phase two clinical trials. Photo: The State-owned Assets Supervision and Administration Commission Inside one of the new production facilities the China National Biotec Group (CNBG) has built for manufacturing a Covid-19 vaccines CNBG announced that one of the potential vaccine candidates had completed phase one and phase two clinical trials. Photo: The State-owned Assets Supervision and Administration Commission
Inside one of the new production facilities the China National Biotec Group (CNBG) has built for manufacturing a Covid-19 vaccines CNBG announced that one of the potential vaccine candidates had completed phase one and phase two clinical trials. Photo: The State-owned Assets Supervision and Administration Commission

Coronavirus: Chinese firm says its vaccine candidate passes phase two clinical trials

  • China National Biotec Group (CNBG) says tests show its vaccine is safe, and now looks to clinical trials overseas
  • China has five vaccines under clinical study, with Sinovac Biotech’s candidate also completing a phase two trial

Topic |   Coronavirus pandemic
Inside one of the new production facilities the China National Biotec Group (CNBG) has built for manufacturing a Covid-19 vaccines CNBG announced that one of the potential vaccine candidates had completed phase one and phase two clinical trials. Photo: The State-owned Assets Supervision and Administration Commission Inside one of the new production facilities the China National Biotec Group (CNBG) has built for manufacturing a Covid-19 vaccines CNBG announced that one of the potential vaccine candidates had completed phase one and phase two clinical trials. Photo: The State-owned Assets Supervision and Administration Commission
Inside one of the new production facilities the China National Biotec Group (CNBG) has built for manufacturing a Covid-19 vaccines CNBG announced that one of the potential vaccine candidates had completed phase one and phase two clinical trials. Photo: The State-owned Assets Supervision and Administration Commission
READ FULL ARTICLE